This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-19 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Jessica Stolee, PhD
Associate Director, Pharma and ASO Analytical Deve at Biogen


Dr. Stolee leads the pharmaceutical and antisense oligonucleotide analytical development group at Biogen, a Massachusetts-based biotechnology company focused on neurological diseases. Her group supports pharmaceutical and oligonucleotide process development and manufacturing and is responsible for evaluating and implementing new technologies for their analysis. Dr. Stolee was one of the primary authors of the CMC portion of Biogen’s first oligonucleotide NDA (Spinraza) and continues to support the global filings.  She received her Ph.D. in Chemistry from George Washington University where her work focused on the development of novel ionization methods for mass spectrometry.

Jessica Stolee, PhD's Network

Agenda Sessions

  • Analytical Strategies for Oligonucleotides

  • SESSION NAME: Analytical Strategies for Oligonucleotides SESSION CHAIRS & SPEAKERS BELOW:

    On Demand